{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:56:18Z","timestamp":1776257778416,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jash.2013.06.004","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T14:45:35Z","timestamp":1374590735000},"page":"471-476","source":"Crossref","is-referenced-by-count":34,"title":["Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence"],"prefix":"10.1016","volume":"7","author":[{"given":"Larissa","family":"Grigoryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valory N.","family":"Pavlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2013.06.004_bib1","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.06.004_bib2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00004872-200111000-00018","article-title":"High prevalence of cardiac and extracardiac target organ damage in refractory hypertension","volume":"19","author":"Cuspidi","year":"2001","journal-title":"Journal Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003-2008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.06.004_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.06.004_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1751-7176.2011.00556.x","article-title":"Refractory hypertension: definition, prevalence, and patient characteristics","volume":"14","author":"Acelajado","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2013.06.004_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1751-7176.2012.00690.x","article-title":"Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension","volume":"14","author":"Irvin","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2013.06.004_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.06.004_bib8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.06.004_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0b013e328353634e","article-title":"Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs","volume":"30","author":"de la Sierra","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib10","article-title":"Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects","author":"Barochiner","year":"2012","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.111.180497","article-title":"Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents","volume":"58","author":"Hanselin","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.06.004_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00149831-200506000-00010","article-title":"Adherence to antihypertensive treatment: a critical factor for blood pressure control","volume":"12","author":"Yiannakopoulou","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jash.2013.06.004_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ajh.2012.30","article-title":"Predictors of antihypertensive medication adherence in two urban health-care systems","volume":"25","author":"Grigoryan","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ajh.2008.240","article-title":"A practice-based trial of motivational interviewing and adherence in hypertensive African Americans","volume":"21","author":"Ogedegbe","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCOUTCOMES.109.849984","article-title":"Does reducing physician uncertainty improve hypertension control? rationale and methods","volume":"2","author":"Pavlik","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jash.2013.06.004_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11606-011-1888-1","article-title":"Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives\u2013a cluster randomized trial","volume":"27","author":"Hyman","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jash.2013.06.004_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2165\/00003495-199448010-00003","article-title":"Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?","volume":"48","author":"Sica","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jash.2013.06.004_bib18","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0149-2918(97)80017-3","article-title":"Patterns of antihypertensive use among patients in the us department of defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker","volume":"19","author":"Okano","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.jash.2013.06.004_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00005650-199909000-00002","article-title":"Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy","volume":"37","author":"Choo","year":"1999","journal-title":"Med Care"},{"key":"10.1016\/j.jash.2013.06.004_bib20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0735-1097(01)01827-7","article-title":"Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects","volume":"39","author":"Verdecchia","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2013.06.004_bib21","first-page":"CD002003","article-title":"Beta-blockers for hypertension","volume":"8","author":"Wiysonge","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jash.2013.06.004_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11883-010-0157-9","article-title":"The role of beta-blockers as first-line therapy in hypertension","volume":"13","author":"De Caterina","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jash.2013.06.004_bib23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2010.07.053","article-title":"Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials","volume":"57","author":"Messerli","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jash.2013.06.004_bib24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0895-7061(01)02193-8","article-title":"Is resistant hypertension really resistant?","volume":"14","author":"Brown","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/jhh.2010.108","article-title":"How common is true resistant hypertension?","volume":"25","author":"Bunker","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2013.06.004_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08037051.2012.727253","article-title":"Optimizing blood pressure control in hypertension: The need to use abpm","volume":"22","author":"Schmieder","year":"2013","journal-title":"Blood Press"},{"key":"10.1016\/j.jash.2013.06.004_bib27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.109.133389","article-title":"Intensifying therapy for hypertension despite suboptimal adherence","volume":"54","author":"Rose","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.06.004_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1751-7176.2011.00427.x","article-title":"Effects of daily adherence to antihypertensive medication on blood pressure control","volume":"13","author":"Rose","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2013.06.004_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/jch.12030","article-title":"Patterns of nonadherence to antihypertensive therapy in primary care","volume":"15","author":"Grigoryan","year":"2013","journal-title":"J\u00a0Clin Hypertens (Greenwich)"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171113001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171113001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T11:28:15Z","timestamp":1539516495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171113001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1933171113001216"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2013.06.004","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}